[Early changes in vascular graft rejection in transplanted kidneys: the past and the present]. 1994

P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
Mikrobiologický ústav Akademie vĕd CR, Praha.

BACKGROUND With maintenance azathioprine+prednisone and in biopsies performed exceptionally earlier than in the 4th week (1966-1984, 476 cadaveric kidney transplantations), prevalence of obliterative arteriopathy (OA, transmural arteritis, 4/III/v3 Banff classif.) was 22.1%, with graft loss by rejection within 6 mos. in 89.4%. The aim of this analysis was to study prevalence and prognostic importance of the former and of further early vascular lesions in subjects with maintenance cyclosporin A using biopsies performed as early as in the 1st week. RESULTS In a retrospective study on 449 transplantation (1987-92, cyclosporin A+prednisone+azathioprine, 64.7% grafts histologically--mostly repeatedly--examined), prevalence and prognostic classification (A-good, B-uncertain, C-poor prognosis) in recipients with OA, with cellular arteriopathy (CA, intimal arteritis, 4/II-III/v2-v3 Banff classif.) and with minimal arterial lesions (MZ) were assessed. Prevalence of OA was found to be 7.1% transplantations, with graft loss by rejection within 6 mos. in 71.9%, and with A:C proportion 25.0%: 62.5%. CA was found in 5.1% and showed A:C proportion 34.7%: 34.7%; in 6/13 cases with repeated histology, OA was later encountered, which is a strong point against its humoral pathogenesis. Prevalence of MZ was 10.9%, with A:C proportion 40.8: 4.1%. CONCLUSIONS Both OA and CA are related to rejection, while the etiology of MZ remains to be clarified. With cyclosporine, prevalence of OA markedly decreased and its prognosis somewhat improved; secondary prevention is possible when an early diagnosis (early and repeated biopsies) is done and immediate treatment (antilymphocyte globulins) started.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D012077 Renal Artery A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. Arteries, Renal,Artery, Renal,Renal Arteries
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
February 2013, Nature reviews. Nephrology,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
November 1978, Schweizerische medizinische Wochenschrift,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
February 2016, Tissue engineering. Part B, Reviews,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
December 1971, California medicine,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
October 1979, La Nouvelle presse medicale,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
January 1980, Annals of biomedical engineering,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
July 1970, Nordisk medicin,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
January 1983, Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
January 1975, Journal de radiologie, d'electrologie, et de medecine nucleaire,
P Rossmann, and J Jirka, and M Chadimová, and I Reneltová, and J Lácha, and J Skibová, and I Matl
March 1982, Human pathology,
Copied contents to your clipboard!